Heavy or regular alcohol blunts results, disrupts sleep and recovery, and adds liver and metabolic strain
The purpose of this chapter is to provide the healthcare practitioner with detailed information on the existing oral and injectable (non-insulin) pharmacological options available for the treatment of patients with T2DM
Understanding this mechanism helps explain the impressive blood sugar results observed in clinical research
5.3 Combination therapies 5.3.1 Low-dose IL-2 It is well-established that IL-2 plays a pivotal role in T cell development, demonstrating a preferential capacity to promote the expansion and functional specialization of Treg, Th1, Th2, and Th9 cells, while it does not directly support the differentiation of Th17 and T follicular helper (Tfh) cells (261, 262)
They are not magic solutions, require long-term commitment (both financial and behavioral), often cause side effects that affect quality of life, and may not work for everyone
